PATENT CLAIM ANALYSIS

Application Number: 16070950
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "229500"]

Abstract:
The present disclosure relates to compositions and methods for treating cancer in a subject having cancer cells over-expressing a microphthalmia (MiT) transcription factor with apilimod and related compositions and methods.

Claim (Index 44):
The method of  claim 42 , wherein the MiT transcription factor is selected from the group consisting of TFEB, TFE3, TFEC, and MITF.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 95.0
- Lexical Diversity: 1.22222
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15524844', '15113154', '15213829', '15645544', '15653814']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.802366749522425
- 35 USC 102 Novelty (BERT): 0.532574661551924
- Combined Prediction Score: 0.775387540725375
- Mean Citation Score: 258.26259
- Max Citation Score: 353.7962
- Similarity Product: 173.75134294804332

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test